1. Does the U.S. Government have:

a. a moral and ethical responsibility to aid African countries dealing with the HIV epidemic?

b. a legal responsibility to aid African countries dealing with the HIV epidemic?

15%

30%

35%

12%

8%

c. a responsibility to use federal monies to aid African countries dealing with the HIV epidemic?

0%

5%

11%

46%

36%

2. Should the US government and international pharmaceutical companies refrain from attempts to challenge economical cost-based production of HIV antivirals for the developing world?

Yes

No

Uncertain

38%

35%

28%

3. Should pharmaceutical companies which invest in expensive drug development for the treatment of HIV/AIDS have different financial interests in the sale of these drugs in the developing and the
developed world?

Yes

No

Uncertain

67%

16%

16%

4. Should the US encourage the WHO and developing nation governments to recommend against breastfeeding--a complex decision that has cultural as well as public health implications?

Yes

No

Uncertain

26%

48%

26%

5. The HIV antiviral that can prevent transmission of virus from mother to infant requires only two doses, therefore is relatively inexpensive. Medication for more prolonged treatment of infected mothers or babies in developing countries is unavailable at present. Is this "2 dose" intervention to decrease mother-to-child transmission appropriate when mothers will die of their infection, leaving orphaned children (who may reach 40 million in number by 2010)?

Yes

No

Uncertain

80%

3%

17%

6. Does the US government have a moral and ethical responsibility to redirect some of our budget surplus to help relieve the suffering of orphaned children (whether or not they are infected with HIV)?

Yes

No

Uncertain

68%

12%

20%

7. The randomized clinical trial with the use of placebo is the "gold standard" for most definitive studies, particularly for vaccine and prevention intervention studies. However, the use of the placebo
has become very controversial in developing countries. Should US researchers continue to insist on the use of placebos in these research settings?

Yes

No

Uncertain

44%

18%

38%

8. Is it ethical to conduct HIV research that may ultimately benefit the participants or others in their country under a standard of care that is only equal to that currently available in the country and not equal to that in the donor country?

Yes

No

Uncertain

33%

38%

28%